Herbas VPB

Print
EN | LT
LT - METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES
EN - METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07K 16/22
A61K 39/395
A61P 43/00
A61K 39/00
European patent
(11) Number of the document 2797953
(13) Kind of document T
(96) European patent application number 12805890.6
Date of filing the European patent application 2012-12-11
(97) Date of publication of the European application 2014-11-05
(45) Date of publication and mention of the grant of the patent 2020-06-03
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/US2012/068975
Date 2012-12-11
PCT application publication
(87) Number WO 2013/101451
Date 2013-07-04
Priority applications
(30) Number Date Country code
201161580964 P 2011-12-28 US
Inventors
(72)
KE, Hua, Zhu, US
LIU, Min, US
GIANNOBILE, William, V., US
Grantee
(73) The Regents of the University of Michigan, 1600 Huron Parkway, 2nd Floor, Ann Arbor, MI 48109-2590, US
Amgen Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, US
Title
(54) METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES
  METHOD OF TREATING ALVEOLAR BONE LOSS THROUGH THE USE OF ANTI-SCLEROSTIN ANTIBODIES
Last update date 2021-04-30